Qualcomm Incorporated has unveiled 10 startups selected for the 2026 edition of its Make in Africa Mentorship Programme, reaffirming its commitment to advancing the continent’s deep-technology ...

Startups in Nigeria and other parts of the continent have, through their innovation, are pushing the boundaries of what ...

Local startup, Amperra Charging Company, has been selected as one of ten African startups for the fourth year of the Qualcomm Make in Africa mentorship programme. Amperra is an AI driven, grid ...

Uganda’s TWave Ltd , who have pioneered an automated, solar‑powered fish feeding system that optimizes aquaculture ...

With this fourth edition, Qualcomm reaffirms its commitment to empowering Africa’s deep-technology ecosystem through mentorship, training, and IP generation initiatives Qualcomm Incorporated today ...

The Artemis Watch 2.0, made by CircuitMess, is a $129 programmable smartwatch designed less as a gadget you wear and more as something you can digitally rebuild into your own creation.

Everything on the electromagnetic spectrum has some properties of both waves and particles, but it’s difficult to imagine a ...

An 80-Cent Robotics Hack: Challenging Asimov’s Laws in Half an Hour Understanding Asimov’s Three Laws of Robotics Isaac Asimov’s iconic ...

The stock of Wave Life Sciences Ltd. (WVE) is down >50% so far today, trading at a value of ~$6 at the time of writing (market cap of $1.2bn), after the Singapore-headquartered biotech reported ...

People flock Baker Beach near the Golden Gate Bridge as heat advisory issued in San Francisco, California, on March 16, 2026. Reporter A historic March heat wave has brought record-breaking ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...

Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down by more than 50% despite the biotech hailing the data as ...